Literature DB >> 17067096

[Pulmonary embolism and Behçet's disease].

S Hammami1, F Addad, N Kaoubaa, M Golli, W Chebbi, A Hamzaoui, M Hammami, M Ben Farhat, S Majhoub.   

Abstract

Pulmonary embolism is an unusual complication of Behçet's disease. Our aim study is to analyse epidemiological, physiopathological and evolutive aspects of this condition. Among 153 patients with Behçet's disease according to the criteria of the International Study Group for Behçet's disease, seven (5 men and 2 women mean aged at 26.6 +/- 6 years) were diagnosed as having pulmonary embolism. This was inaugural in 3 cases; for 2 females, pulmonary embolism complicated pregnancy. Cardiac thrombosis was presented in 2 cases and pulmonary aneurysm in 2 patients. Pulmonary infarction has been noted in 4 cases. Protein C, protein S and antithrombin III levels were normal in all cases. One patient was positive for IgG anticardiolipin antibody. The hyperhomocysteinemia has been noted (17 to 30 micromol/) in 5 cases. All our patients were treated successfully by anticoagulation therapy combined with high dose prednisone, colchicine and intravenous cyclophosphamide in 6 patients. Pulmonary embolism is one of the severe and worst prognostic manifestations of the disease. Furthermore, the hyperhomocysteinemia may play an important role in the pathogenesis of such complication. Immunomodulation therapy associated to folate may be beneficial to attenuate this hyperhomocysteinemia especially, when introduced in the early stages.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17067096

Source DB:  PubMed          Journal:  Arch Mal Coeur Vaiss        ISSN: 0003-9683


  2 in total

1.  A rare case of behçet disease presenting with pyrexia of unknown origin, pulmonary embolism, and right ventricular thrombus.

Authors:  Weili Xing; Girider Swaminathan; Dorai Raj Appadorai; Ashish Anil Sule
Journal:  Int J Angiol       Date:  2013-09

Review 2.  Intracardiac thrombus in Behçet's disease: four new cases and a comprehensive literature review.

Authors:  Tolga Aksu; Omac Tufekcioglu
Journal:  Rheumatol Int       Date:  2014-11-09       Impact factor: 2.631

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.